To properly understand Globus Medical's profit results, we need to consider the US$200m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first ...

Globus Medical, Inc.’s GMED share price has dipped by 21.03%, which has investors questioning if this is right time to buy.

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after market close. Here’s ...

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors ...

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.

GMED opened at $55.54 on Friday. The business’s 50-day moving average price is $72.21 and its two-hundred day moving average price is $79.94. Globus Medical has a 1 year low of $54.48 and a 1 ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended March 2025. While this widely-known consensus outlook ...

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company ...